The European payer landscape is very fragmented and complex. Using payer archetypes helps to bring clarity in this complex maze by categorising payers based on similar characteristics.
CELforPharma faculty member Dr Nick Proctor, expert-trainer of the Understanding Pharma Market Access & Payers in Europe course, has made a handy slide snapshot that shows different ways to do this.
🎓 If you want to learn about:
- The patterns in pricing & reimbursement systems and processes in France, Germany, Italy, Spain and the UK.
- Market access challenges and opportunities in these countries.
- How to differentiate between different categories of payers.
- Payer archetypes and the drivers of their decision-making processes.
- The market access plan and process, and the contributions of internal stakeholders across functions.
- The types of Managed Entry Agreements used by payers and pharma to mitigate risk.
👉 Attend Dr Nick Proctor’s highly praised 1-day course:
Understanding Pharma Market Access & Payers in Europe
With Dr Nick Proctor
